(Q38819228)

English

Radionuclide therapy using ¹³¹I-labeled anti-epidermal growth factor receptor-targeted nanoparticles suppresses cancer cell growth caused by EGFR overexpression

scientific article published on 16 November 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Radionuclide therapy using ¹³¹I-labeled anti-epidermal growth factor receptor-targeted nanoparticles suppresses cancer cell growth caused by EGFR overexpression (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

1 reference

based on heuristic

inferred from title

0 references

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26573511%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

author name string

Zhongyun Liu

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26573511%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Chengxia Li

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26573511%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Ning Li

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26573511%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Lei Fang

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26573511%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Jin Chang

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26573511%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Jian Tan

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26573511%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

publication date

16 November 2015

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Journal of Cancer Research and Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26573511%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

142

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26573511%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26573511%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

619-632

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26573511%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

https://scigraph.springernature.com/pub.10.1007/s00432-015-2067-2

0 references

Biodegradable dendritic positron-emitting nanoprobes for the noninvasive imaging of angiogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2067-2

21 January 2018

Anti-prostate-specific membrane antigen liposomes loaded with 225Ac for potential targeted antivascular α-particle therapy of cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2067-2

21 January 2018

Pertuzumab: new hope for patients with HER2-positive breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2067-2

21 January 2018

Tumour therapy with radionuclides: assessment of progress and problems.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2067-2

21 January 2018

Dual-modality optical and positron emission tomography imaging of vascular endothelial growth factor receptor on tumor vasculature using quantum dots

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2067-2

21 January 2018

Mechanism-based tumor-targeting drug delivery system. Validation of efficient vitamin receptor-mediated endocytosis and drug release.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2067-2

21 January 2018

A low-molecular-weight heparin-coated doxorubicin-liposome for the prevention of melanoma metastasis

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2067-2

21 January 2018

Cetuximab-conjugated magneto-fluorescent silica nanoparticles for in vivo colon cancer targeting and imaging

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2067-2

21 January 2018

Iron oxide nanoparticle-induced epidermal growth factor receptor expression in human stem cells for tumor therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2067-2

21 January 2018

Antinucleosome antibody-modified liposomes and lipid-core micelles for tumor-targeted delivery of therapeutic and diagnostic agents

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2067-2

21 January 2018

In vitro evaluation and biodistribution of HER2-targeted liposomes loaded with an (125)I-labelled DNA-intercalator.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2067-2

21 January 2018

HER1/EGFR-targeted agents: predicting the future for patients with unpredictable outcomes to therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2067-2

21 January 2018

Monoclonal antibody 2C5-modified doxorubicin-loaded liposomes with significantly enhanced therapeutic activity against intracranial human brain U-87 MG tumor xenografts in nude mice

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2067-2

21 January 2018

Targeted delivery of dendritic polyglycerol-doxorubicin conjugates by scFv-SNAP fusion protein suppresses EGFR+ cancer cell growth

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2067-2

21 January 2018

99mTc-Hydrazinonicotinamide epidermal growth factor-polyethylene glycol-quantum dot imaging allows quantification of breast cancer epidermal growth factor receptor expression and monitors receptor downregulation in response to cetuximab therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2067-2

21 January 2018

Evaluation of EGFR-targeted radioimmuno-gold-nanoparticles as a theranostic agent in a tumor animal model

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2067-2

21 January 2018

Tumor targeting and imaging using cyclic RGD-PEGylated gold nanoparticle probes with directly conjugated iodine-125.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2067-2

21 January 2018

PET/MRI dual-modality tumor imaging using arginine-glycine-aspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2067-2

21 January 2018

A novel antiangiogenesis therapy using an integrin antagonist or anti-Flk-1 antibody coated 90Y-labeled nanoparticles

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2067-2

21 January 2018

Self-assembled biodegradable protein-polymer vesicle as a tumor-targeted nanocarrier.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2067-2

21 January 2018

Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2067-2

21 January 2018

EGFR-targeted immunoliposomes derived from the monoclonal antibody EMD72000 mediate specific and efficient drug delivery to a variety of colorectal cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2067-2

21 January 2018

Tumor targeting with antibody-functionalized, radiolabeled carbon nanotubes

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2067-2

21 January 2018

Antibody-targeted radiation cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2067-2

21 January 2018

Nanocarriers for nuclear imaging and radiotherapy of cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2067-2

21 January 2018

Flavopiridol synergizes with sorafenib to induce cytotoxicity and potentiate antitumorigenic activity in EGFR/HER-2 and mutant RAS/RAF breast cancer model systems

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2067-2

21 January 2018

Cellular studies of binding, internalization and retention of a radiolabeled EGFR-binding affibody molecule

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2067-2

21 January 2018

Implications for KRAS status and EGFR-targeted therapies in metastatic CRC.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2067-2

21 January 2018

Arabinogalactan-folic acid-drug conjugate for targeted delivery and target-activated release of anticancer drugs to folate receptor-overexpressing cells

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2067-2

21 January 2018

Nanoparticulate drug delivery systems for cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2067-2

21 January 2018

PEG/RGD-modified magnetic polymeric liposomes for controlled drug release and tumor cell targeting

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2067-2

21 January 2018

Nanotargeted radionuclides for cancer nuclear imaging and internal radiotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2067-2

21 January 2018

Pharmacokinetic analysis of 111 in-labeled liposomal Doxorubicin in murine glioblastoma after blood-brain barrier disruption by focused ultrasound

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2067-2

21 January 2018

In vitro and in vivo anti-tumor activities of anti-EGFR single-chain variable fragment fused with recombinant gelonin toxin

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2067-2

21 January 2018

A pH-sensitive doxorubicin prodrug based on folate-conjugated BSA for tumor-targeted drug delivery

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2067-2

21 January 2018

Imaging of Vx-2 rabbit tumors with alpha(nu)beta3-integrin-targeted 111In nanoparticles

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2067-2

21 January 2018

An aptamer-siRNA chimera suppresses HIV-1 viral loads and protects from helper CD4(+) T cell decline in humanized mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/26573511

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The nuclear epidermal growth factor receptor signaling network and its role in cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26573511

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR- and EGFRvIII-overexpressing tumor cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26573511

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Doxorubicin-loaded Fab' fragments of anti-disialoganglioside immunoliposomes selectively inhibit the growth and dissemination of human neuroblastoma in nude mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/26573511

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26573511

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal growth factor receptor-targeted ultra-small superparamagnetic iron oxide particles for magnetic resonance molecular imaging of lung cancer cells in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/26573511

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00432-015-2067-2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26573511%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26573511%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38819228&oldid=2165371457"